January 25th, 2009
Podcast 27: Dr. Steven E. Sobol talks with us about his paper on trends in pediatric head-and-neck infections from S. aureus — an increasing percentage of which are MRSA.
Podcast: Play in new window | Download
Subscribe: RSS
The 6-year period 2001 – 2006 saw an increase from 12 to 28 in the percentage of S. aureus infections among head-and-neck infections in childen that were methicillin resistant. This 16-point jump is concerning, and we talk with an author of the paper documenting that increase.
Also, we’d like to know: should we be calling this thing here “Admitting Diagnosis” — or something else?
If you would like to comment or offer an idea for a future podcast, please call 617-440-4374.
Links for this podcast:
- Steroids and wheezing children
- Journal Watch Pediatrics & Adolescent Medicine summary
- NEJM prednisolone abstract
- NEJM fluticasone abstract
- Journal Watch General Medicine coverage of benefits of antidepressants in fibromyalgia
- JAMA fibromyalgia abstract from Pubmed
- Physician’s First Watch coverage of MRSA study
- Archives of Otolaryngology abstract
Categories: Audio, epidemiology
Tags: antidepressants, corticosteroids, fibromyalgia, fluticasone, Infectious Diseases, MRSA, prednisolone, S. aureus, Steven E. Sobol, viral infections, wheezing
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Most Commented
- Podcast 256 — Anthony Fauci: Talking with patients about COVID-19 (27)
- Podcast 266: Interferon and early treatment in COVID-19 bring good outcomes (8)
- Podcast 251: Intermittent fasting (7)
- Podcast 214: Drug-drug interactions and bleeding risks with NOACs (6)
- Podcast 261: COVID-19 as a medical disaster (6)
Subscribe to Clinical Conversations via Email
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin